[
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-1",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#definitiongeneral234860",
    "clean_content": "Definition / general\n\n* Certain drugs may give rise to soft lymph node enlargement, predominantly in the neck ([J Pathol Bacteriol 1968;95:314](5643463))* Lymphadenopathy may occur alone or be associated with involvement of other organs ([Neurology 1979;29:1480](574201))* May resemble lymphoma by morphology* When the drug is stopped, the lymphadenopathy usually disappears in 1 - 2 weeks* Can present with lymphadenopathy or with a rare systemic disorder, DIHS / DRESS (Drug Induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms ([Rev Assoc Med Bras 2016;62:227](27310545))"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-2",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#essentialfeatures234861",
    "clean_content": "Essential features\n\n* History of drug exposure* Polymorphous infiltrate composed of immunoblasts, small lymphocytes, plasma cells, eosinophils and histiocytes"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-3",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#terminology234862",
    "clean_content": "Terminology\n\n* Drug induced lymphadenopathy* Hydantoin lymphadenopathy* Pseudolymphoma syndrome* Drug induced hypersensitivity syndrome (DIHS)* Drug reaction with eosinophilia and systemic symptoms (DRESS)"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-4",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#icdcoding234863",
    "clean_content": "ICD coding\n\n* [R59.9](http://www.icd10data.com/ICD10CM/Codes/R00-R99/R50-R69/R59-/R59.9)"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-5",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#epidemiology234864",
    "clean_content": "Epidemiology\n\n* Uncommon* Pediatric population"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-6",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#sites234865",
    "clean_content": "Sites\n\n* Predominantly cervical but all lymph node groups can be affected* Can be generalized"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-7",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#pathophysiology234866",
    "clean_content": "Pathophysiology\n\n* Different theories have been proposed:\n  + Hapten: drug molecules become antigenic when bound to a carrier protein, creating an immune response ([Curr Opin Immunol 2012;24:730](23062470))+ p-i concept: direct binding of drugs and their metabolites to HLA trigger T cell responses ([Curr Opin Allergy Clin Immunol 2002;2:301](12130944))+ Very strong link between HLA-B\\*5701 in HIV positive Caucasians and the development of hypersensitivity to abacavir\n        - Abacavir binds noncovalently and specifically to the peptide binding groove of HLA-B\\*5701 molecule ([Nature 2012;486:554](22722860))+ Susceptibility to carbamazepine reactions in patients with HLA-B\\*1502 variant ([Nature 2004;428:486](15057820))+ Drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with reactivation of inactive Herpesviridae family viruses, including human herpesvirus 6 (HHV6), Epstein-Barr virus (EBV) and cytomegalovirus (CMV) ([Arch Dermatol 2001;137:301](11255328), [Br J Dermatol 2006;155:344](16882173), [Arch Dermatol 2009;145:1030](19770444))"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-8",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#etiology234867",
    "clean_content": "Etiology\n\n* Reaction to drug exposure, including ([Am J Med 2011;124:588](21592453)):\n  + Abacavir, allopurinol, antibiotics, carbamazepine, dapsone+ Lamotrigine, mexiletine, minocycline, nevirapine+ Oxcarbazepine, phenobarbital, phenytoin ([J Pathol Bacteriol 1968;95:314](5643463), [Neurology 1979;29:1480](574201)), salazosulfapyridine+ Sulfamethoxazole, sulfasalazine, strontium ranelate, vancomycin"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-9",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#clinicalfeatures234868",
    "clean_content": "Clinical features\n\n* Isolated lymph node enlargement OR* Drug Induced Hypersensitivity Syndrome (DIHS) / Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) ([Allergol Int 2016;65:432](27134114)):\n    + Fever, lymphadenopathy, facial edema, periorbital edema, conjunctival injection+ Abdominal pain, diarrhea, hepatomegaly, splenomegaly+ Skin rash (maculopapular rash, bullous, wheal and flare, plaque, patch, target lesion)+ Internal organ involvement (liver - elevated alanine aminotransferase levels, kidney, lung); also brain ([Turk J Pediatr 2015;57:541](27411428)), heart, muscle, pancreas, thyroid ([Int J Mol Sci 2017 Jun 9;18(6) pii: E1243](28598363))+ Hematologic abnormalities (eosinophilia, atypical lymphocytes, lymphocytosis, lymphopenia, thrombocytopenia)"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-10",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#diagnosis234869",
    "clean_content": "Diagnosis\n\n* Clinical history of drug exposure* Characteristic clinical and laboratory features* Biopsy of the affected lymph node (rarely done, not required for diagnosis)"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-11",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#radiologydescription234870",
    "clean_content": "Radiology description\n\n* Enlarged lymph nodes"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-12",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#prognosticfactors234871",
    "clean_content": "Prognostic factors\n\n* Underlying disease conditions* Extent of drug exposure* Drug reaction with eosinophilia and systemic symptoms (DRESS) has 4% mortality ([Acta Derm Venereol 2012;92:200](22002792))"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-13",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#casereports234872",
    "clean_content": "Case reports\n\n* 17 year old girl presenting with bilateral cervical neck lymphadenopathy ([Int J Pediatr Otorhinolaryngol 2017;98:82](28583510))* 20 year old woman with fever of 38Â°C, prostration and drowsiness ([Rev Assoc Med Bras 2016;62:227](27310545))* 24 year old woman with lamotrigine cervical pseudolymphoma ([Epilepsy Behav Case Rep 2017;7:40](28348962))* 37 year old woman with redness and edema of inguinal area ([Drug Saf Case Rep 2017;4:1](28000142))* 60 year old man with skin rash, fever, distended abdomen and severe pruritus for 10 days ([Iran Red Crescent Med J 2016;18:e36825](28144463))"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-14",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#treatment234873",
    "clean_content": "Treatment\n\n* Discontinuation of the offending drug* For severe cases, immunosuppressive drugs / corticosteroids, IV Ig, plasma exchange"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-15",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#grossdescription234874",
    "clean_content": "Gross description\n\n* Enlarged lymph nodes"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-16",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#microscopichistologicdescription234875",
    "clean_content": "Microscopic (histologic) description\n\n* Polymorphous cellular infiltrate composed of lymphocytes, plasma cells, eosinophils and histiocytes, most often with architectural distortion* Focal hemorrhagic necrosis is usually seen without fibrosis or scarring* Typical multinucleated Reed-Sternberg cells are absent; however, cells resembling Hodgkin / Reed-Sternberg (HRS) cells may be seen* Blood vessels show endothelial hyperplasia* There is variable follicular and paracortical hyperplasia\n          ([Hum Pathol 1974;5:519](4137045))"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-17",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Flow cytometry description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#flowcytometrydescription234876",
    "clean_content": "Flow cytometry description\n\n* No aberrant immunophenotype"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-18",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#molecularcytogeneticsdescription234877",
    "clean_content": "Molecular / cytogenetics description\n\n* No clonal cell populations"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-19",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#differentialdiagnosis234878",
    "clean_content": "Differential diagnosis\n\n* For drug reaction with eosinophilia and systemic symptoms (DRESS) ([Rev Assoc Med Bras 2016;62:227](27310545)):\n  + [Hypereosinophilic syndrome](https://www.pathologyoutlines.com/topic/myeloproliferativehypereosinophilicsyndrome.html): manifests with urticaria and angioedema and can be a hematopoietic malignancy+ [Kawasaki disease](https://www.pathologyoutlines.com/topic/lymphnodeskawasaki.html): presents with mucosal congestion and desquamation of extremities / skin and lacks eosinophilia and atypical lymphocytes+ [Stevens-Johnson syndrome / toxic epidermal necrolysis](https://www.pathologyoutlines.com/topic/skinnontumorstevensjohnsonsyndrome.html): lacks eosinophilia, atypical lymphocytosis and lymphadenopathy* On lymph node biopsy ([Hum Pathol 1974;5:519](4137045)):\n    + [Angioimmunoblastic T cell lymphoma (AITL)](https://www.pathologyoutlines.com/topic/lymphomanonBAITL.html):\n      - Presence of vascular proliferation, immunoblasts and polymorphous infiltrate cause confusion with angioimmunoblastic T cell lymphoma- AITL has characteristic T cells of T follicular helper (TFH) phenotype in perisinusoidal areas and T cell clones, not seen in drug hypersensitivity+ [Hodgkin lymphoma](https://www.pathologyoutlines.com/topic/lymphomanonBclassic.html):\n        - Presence of polymorphous inflammatory infiltrate and large Hodgkin / Reed-Sternberg-like cells may cause confusion- However, classic Hodgkin / Reed-Sternberg cells are not identified in drug hypersensitivity"
  },
  {
    "id": "drug-hypersensitivity_1953_1750165657.txt-20",
    "source_document": "drug-hypersensitivity_1953_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesdrughypersensitivity.html#additionalreferences234879",
    "clean_content": "Additional references\n\n* [Am Fam Physician 2014;89:353](24695506), [J Pathol Bacteriol 1968;95:314](5643463), [Front Med (Lausanne) 2017;4:179](29255708), [Neurology 1979;29:1480](574201)"
  }
]